Tutorials
Vera Therapeutics Inc logo

Vera Therapeutics Inc

$ 20.35 +1 (+5.17%) 08:08 PM EST
P/E:
At Loss
P/B:
3.89
Market Cap:
$ 552.33M
Enterprise V:
$ 387.03M
Volume:
92.21K
Avg Vol (2M):
73.90K
Volume:
92.21K
Market Cap $:
552.33M
PE Ratio:
At Loss
Avg Vol (2-Month):
73.90K
Enterprise Value $:
387.03M
PB Ratio:
3.89
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Vera Therapeutics Inc
NAICS : 325412 SIC : 2834
8000 Marina Boulevard, Suite 120, Brisbane, CA, USA, 94005
Description
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 11.81
Equity-to-Asset 0.82
Debt-to-Equity 0.1
Debt-to-EBITDA -0.29
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 83.85
9-Day RSI 78.49
14-Day RSI 73.29
6-1 Month Momentum % -23.48
12-1 Month Momentum % -15.21

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.9
Quick Ratio 7.9
Cash Ratio 7.56

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -78
ROA % -45.96
ROIC % -1415.19
ROC (Joel Greenblatt) % -1324.5
ROCE % -49.81

Financials (Next Earnings Date:2022-11-10 Est.)

VERA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:VERA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.19
Beta 0
Volatility % 110.26
14-Day RSI 73.29
14-Day ATR ($) 1.339304
20-Day SMA ($) 17.518
12-1 Month Momentum % -15.21
52-Week Range ($) 12.285 - 37.11
Shares Outstanding (Mil) 27.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vera Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More